Name | etidocaine |
---|---|
Synonyms |
(2S)-N-(2,6-Dimethylphenyl)-2-[ethyl(propyl)amino]butanamide
Butanamide, N-(2,6-dimethylphenyl)-2-(ethylpropylamino)-, (2S)- 2-ethylpropylamino-2,6-n-butyroxylidide Etidocaine |
Description | Etidocaine (EDC) is a long aminoamide local anesthetic[1]. |
---|---|
Related Catalog | |
In Vitro | IGL-EDC formulations can induce a significant increase in human fibroblasts survival[1]. Cell Viability Assay[1] Cell Line: Human fibroblasts cells Concentration: 0, 4, 8, 16, 24 mM Incubation Time: 4, 6 and 24 h Result: Showed that cell survival decreased in a (EDC) concentration with time-dependent manner. |
In Vivo | Etidocaine (spinal injection, 0.0075%, once) does not show postinjection neurologic deficit[2]. Animal Model: Adult Swiss Webster male mice[2] Dosage: 0.0075% Administration: Etidocaine (spinal injection, 0.0075%, once) Result: Did not show postinjection neurologic deficit. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 389.7±30.0 °C at 760 mmHg |
Molecular Formula | C17H28N2O |
Molecular Weight | 276.417 |
Flash Point | 189.5±24.6 °C |
Exact Mass | 276.220154 |
PSA | 32.34000 |
LogP | 3.77 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.532 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|